Israel's OurCrowd to Raise $100 Million for Coronavirus Technologies
The investment platform's pandemic innovation fund will focus on investing in areas such as vaccines and PPE, as well as related startups
Israeli venture investing platform OurCrowd said on Tuesday it plans to raise $100 million for investment in technology in medical, education and other segments to find solutions for COVID-19 and future pandemics.
Its pandemic innovation fund will focus on investing in areas such as vaccines, personal protection, therapeutics, diagnostics, remote monitoring, digital health, remote working, distance learning, robotic process animation, home exercise, and cybersecurity.
The fund will invest in new startups and relevant companies already included in OurCrowd’s portfolio, which has more than 20 companies actively working to mitigate the coronavirus crisis. Some of these companies, it said, will be candidates for follow-on investment from the PIF.
- 'Digital Health' Can't Be the Cure for Coronavirus, Top Medical Entrepreneur Says
- Israeli Researchers Hope AI Can Tame COVID-19, and They Want Our Help
- As Coronavirus Crisis Gives Push to Digital Medicine, Israeli Startups Answer the Call
“To ensure that we get the world back on track, there is now an urgent need for innovation,” said OurCrowd CEO Jon Medved. “Technology can help us overcome many of the problems resulting from the crisis.”